Skip to main navigation

+44 (0)20 8154 4600
info@achillestx.com

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Press Releases

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Year

All News
2024
2023
2022
2021
2020
2019
2018
2017
2016

Mar 17 2020

Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer

Read More +

Jan 7 2020

Achilles Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Read More +

Nov 28 2019

Achilles Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

Read More +

Nov 14 2019

Achilles Therapeutics to Present at the Jefferies 2019 London Healthcare Conference

Read More +

Oct 21 2019

Achilles Therapeutics Appoints Beverley Carr as Chief Business Officer — Brings 20+ years of business development experience — Formerly VP, Business Development for the Immuno-inflammation Therapy Area at GSK

Read More +

Sep 3 2019

ACHILLES THERAPEUTICS RAISES £100 MILLION IN OVERSUBSCRIBED SERIES B FINANCING

Read More +

Feb 13 2019

ACHILLES THERAPEUTICS RECEIVES CTA APPROVAL FOR PHASE I/II STUDY IN METASTIC OR RECURRENT MELANOMA — Second CTA approval in 2019 — the first was for a NSCLC study

Read More +

Jan 21 2019

ACHILLES THERAPEUTICS RECEIVES CTA APPROVAL FOR PHASE I/II STUDY IN NON-SMALL CELL LUNG CANCER — Ground-breaking clinical trial in patients with significant unmet medical need to start this year

Read More +

Dec 10 2018

ACHILLES THERAPEUTICS APPOINTS DR EDWIN MOSES AS CHAIRMAN OF ITS BOARD OF DIRECTORS AND DR IRAJ ALI AS CHIEF EXECUTIVE OFFICER

Read More +

Sep 19 2018

ACHILLES TODAY ANNOUNCES THAT IT HAS APPOINTED SENIOR PHARMACEUTICAL EXECUTIVE MICHAEL F. GIORDANO, M.D., TO ITS BOARD OF DIRECTORS.

Read More +

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Home
About Us
Science
Publications
Pipeline
Investors & Media
Work with us
Contact

UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK

US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108

+44 (0)20 8154 4600
info@achillestx.com

© Copyright - Achilles Therapeutics plc.

Achilles Therapeutics plc (13027460) is registered in England and Wales. The registered office is at 245 Hammersmith Road, London, W6 8PW.

Privacy & Cookie Policy

Terms & Conditions